Pages that link to "Q48431844"

The following pages link to Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab (Q48431844):

Displaying 38 items.

• Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer (Q26824799) (← links)
• PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer (Q27006181) (← links)
• Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. (Q28082016) (← links)
• Progress in the biological understanding and management of breast cancer-associated central nervous system metastases (Q33777436) (← links)
• Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials (Q33939795) (← links)
• Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients (Q34285753) (← links)
• Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches. (Q35584731) (← links)
• Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient (Q36062188) (← links)
• Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment (Q36469191) (← links)
• Breast cancer brain metastases: new directions in systemic therapy (Q36822500) (← links)
• Carcinomatous meningitis: Leptomeningeal metastases in solid tumors (Q36851197) (← links)
• Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab (Q37289402) (← links)
• Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours (Q37769645) (← links)
• Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis (Q37784351) (← links)
• Leptomeningeal Disease (Q37812451) (← links)
• Revisiting the role of molecular targeted therapies in patients with brain metastases. (Q37904792) (← links)
• Intra-CSF administration of chemotherapy medications (Q38015719) (← links)
• Optimal management of brain metastases from breast cancer. Issues and considerations (Q38067340) (← links)
• Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature (Q38083065) (← links)
• CNS metastases in breast cancer: old challenge, new frontiers (Q38168168) (← links)
• Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update (Q38230553) (← links)
• Emerging insights into barriers to effective brain tumor therapeutics (Q38237653) (← links)
• Trastuzumab in the Treatment of Breast Cancer (Q38739914) (← links)
• Experimental Treatments for Leptomeningeal Metastases From Solid Malignancies (Q38971627) (← links)
• A 4-week intrathecal toxicity and pharmacokinetic study with trastuzumab in cynomolgus monkeys (Q39875718) (← links)
• Sudden hearing loss due to internal auditory canal metastasis of Her2-positive gastric cancer: A case report (Q40893254) (← links)
• Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases (Q43555121) (← links)
• Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades (Q43824194) (← links)
• Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy (Q47133535) (← links)
• Leptomeningeal neoplasms (Q47574507) (← links)
• Care with intrathecal trastuzumab (Q48647277) (← links)
• High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer. (Q48887166) (← links)
• Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer (Q51816001) (← links)
• Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab. (Q54386974) (← links)
• Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment? (Q54592607) (← links)
• Drug-Induced Aseptic Meningitis Associated With Intrathecal Trastuzumab. (Q55411816) (← links)
• Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab (Q56777007) (← links)
• Cerebrospinal Fluid Cytology Diagnosis of HER2-Positive Leptomeningeal Carcinomatosis From HER2-Positive Metastatic Gastric Cancer: Case Report (Q83386616) (← links)